EarningsQ4 2024 Earnings Report

Novavax (NVAX) Q4 2024 Earnings Report

0 Followers

MX:NVAX Q4 2024 EPS Results

Actual EPS-$9.38

Consensus EPS-$9.45

Beat/MissBeat by +$0.07

One Year Ago EPS-$26.48

Actual Revenue$1.62B

Expected Revenue$1.55B

Beat/MissBeat by +$72.30M

YoY Revenue Growth-69.69%

QuarterQ4 2024

Date02/27/2025

TimeBefore Open

Conference CallThursday, February 27, 2025

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-3.97 / -	-22.989	―
Aug 06, 2026	2026 (Q2)	-6.99 / -5.89	11.403	-151.61% (-17.29)
May 06, 2026	2026 (Q1)	-4.45 / -1.10	53.886	-102.05% (-54.99)
Feb 26, 2026	2025 (Q4)	-8.92 / 2.02	-9.379	121.57% (+11.40)
Nov 06, 2025	2025 (Q3)	-22.00 / -22.99	-13.977	-64.47% (-9.01)
Aug 06, 2025	2025 (Q2)	0.15 / 11.40	18.207	-37.37% (-6.80)
May 08, 2025	2025 (Q1)	-7.78 / 53.89	-19.311	379.05% (+73.20)
Feb 27, 2025	2024 (Q4)	-9.45 / -9.38	-26.483	64.58% (+17.10)
Nov 12, 2024	2024 (Q3)	-14.55 / -13.98	-23.173	39.68% (+9.20)
Aug 08, 2024	2024 (Q2)	30.71 / 18.21	10.667	70.69% (+7.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed